These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 18606441

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer.
    Urick ME, Johnson PA.
    Gynecol Oncol; 2006 Nov; 103(2):673-8. PubMed ID: 16797680
    [Abstract] [Full Text] [Related]

  • 3. Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents.
    Rodríguez-Burford C, Barnes MN, Oelschlager DK, Myers RB, Talley LI, Partridge EE, Grizzle WE.
    Clin Cancer Res; 2002 Jan; 8(1):202-9. PubMed ID: 11801560
    [Abstract] [Full Text] [Related]

  • 4. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
    Eibl G, Takata Y, Boros LG, Liu J, Okada Y, Reber HA, Hines OJ.
    Cancer Res; 2005 Feb 01; 65(3):982-90. PubMed ID: 15705899
    [Abstract] [Full Text] [Related]

  • 5. Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer.
    Daikoku T, Tranguch S, Chakrabarty A, Wang D, Khabele D, Orsulic S, Morrow JD, Dubois RN, Dey SK.
    Cancer Res; 2007 Jun 01; 67(11):5285-92. PubMed ID: 17545608
    [Abstract] [Full Text] [Related]

  • 6. [Inhibitory effect of NS398 on the proliferation of human ovarian cancer cell lines CAOV3 and OVCAR3 in vitro].
    Wang CY, Wang M, Wang XY, Zhang SL, Wang YX, Li LK.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jul 01; 38(7):415-8. PubMed ID: 12921553
    [Abstract] [Full Text] [Related]

  • 7. Dietary aspirin decreases the stage of ovarian cancer in the hen.
    Urick ME, Giles JR, Johnson PA.
    Gynecol Oncol; 2009 Jan 01; 112(1):166-70. PubMed ID: 18986688
    [Abstract] [Full Text] [Related]

  • 8. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
    Campos X, Muñoz Y, Selman A, Yazigi R, Moyano L, Weinstein-Oppenheimer C, Lara HE, Romero C.
    Gynecol Oncol; 2007 Jan 01; 104(1):168-75. PubMed ID: 16935322
    [Abstract] [Full Text] [Related]

  • 9. [Effects of nonsteroidal anti-inflammatory drug celecoxib on expression of cyclooxygenase-2 (COX-2) in ovarian carcinoma cell].
    Wang HJ, Liu XJ, Yang KX, Luo FM, Lou JY, Peng ZL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep 01; 37(5):757-60. PubMed ID: 17037745
    [Abstract] [Full Text] [Related]

  • 10. Expression and clinical significance of vascular endothelial growth factor, cyclooxygenase-2, and Bcl-2 in borderline ovarian tumors.
    Li M, Qi SY, Wang Y, Feng SX, Zhang BZ, Wang R.
    Arch Gynecol Obstet; 2005 Jun 01; 272(1):48-52. PubMed ID: 15682318
    [Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins.
    Abdelrahim M, Safe S.
    Mol Pharmacol; 2005 Aug 01; 68(2):317-29. PubMed ID: 15883203
    [Abstract] [Full Text] [Related]

  • 12. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M, Barclay C, Li AW, Geldenhuys L, Porter GA, Blay J, Casson AG, Murphy PR.
    Mol Carcinog; 2007 Dec 01; 46(12):971-80. PubMed ID: 17477358
    [Abstract] [Full Text] [Related]

  • 13. Co-inhibition of cyclooxygenase-2 and dihydropyrimidine dehydrogenase by non-steroidal anti-inflammatory drugs in tumor cells and xenografts.
    Réti A, Pap E, Zalatnai A, Jeney A, Kralovánszky J, Budai B.
    Anticancer Res; 2009 Aug 01; 29(8):3095-101. PubMed ID: 19661321
    [Abstract] [Full Text] [Related]

  • 14. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer.
    Altinoz MA, Korkmaz R.
    Neoplasma; 2004 Aug 01; 51(4):239-47. PubMed ID: 15254653
    [Abstract] [Full Text] [Related]

  • 15. [Down-regulation of vascular endothelial growth factor expression in ovarian cancer cell line SKOV3 by interferon-gamma].
    Lin FF, Chen HZ, Xie X, Ye DF.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar 01; 38(3):150-3, 3-1. PubMed ID: 12816689
    [Abstract] [Full Text] [Related]

  • 16. [Effect of estrogen and progesterone on the expression of VEGF mRNA in epithelial ovarian cancer cell line].
    Li H, Sun H.
    Zhonghua Zhong Liu Za Zhi; 2004 May 01; 26(5):264-7. PubMed ID: 15312358
    [Abstract] [Full Text] [Related]

  • 17. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.
    Liu LT, Chang HC, Chiang LC, Hung WC.
    Oncogene; 2002 Nov 28; 21(54):8347-50. PubMed ID: 12447698
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
    Tanaka K, Suemasu S, Ishihara T, Tasaka Y, Arai Y, Mizushima T.
    Eur J Pharmacol; 2009 Jan 28; 603(1-3):120-32. PubMed ID: 19101538
    [Abstract] [Full Text] [Related]

  • 19. Correlative expression of cyclooxygenase-1 (Cox-1) and human epidermal growth factor receptor type-2 (Her-2) in endometrial cancer.
    Sugimoto T, Koizumi T, Sudo T, Yamaguchi S, Kojima A, Kumagai S, Nishimura R.
    Kobe J Med Sci; 2007 Jan 28; 53(5):177-87. PubMed ID: 18204294
    [Abstract] [Full Text] [Related]

  • 20. [Effects of 5F from Pteri semipinnata on the expression of ETS-1 mRNA and VEGF protein of highly metastatic ovarian carcinoma HO-8910PM cells].
    He T, Mo L, Liang N.
    Zhong Yao Cai; 2005 Apr 28; 28(4):307-9. PubMed ID: 16104507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.